β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction

JAMA

Volumn 288, Issue 3, 2002, Pages 351-357

  Ko, Dennis T ^b   Hebert, Patricia R ^b   Coffey, Christopher S ^d   Sedrakyan, Artyom ^c   Curtis, Jeptha P ^b   Krumholz, Harlan M ^a,b,c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Section of Cardiovascular Medicine   (United States)

^c Section of Health Policy and Administration   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FATIGUE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK; SEXUAL DYSFUNCTION; SYMPTOMATOLOGY;

EID: 0037125378     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.3.351     Document Type: Review

References (46)

1. Beta blockade after myocardial infarction: Systematic review and meta regression analysis
2. Beta-adrenergic receptor blockade in chronic heart failure
3. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project
4. Beta-adrenoceptor antagonists: New drugs and new indications
5. Erectile dysfunction
6. Effects of antihypertensive agents on sexual function
7. Propranolol-induced depression
8. Propranolol and sexual impotence
9. Adverse reactions to beta-adrenergic receptor blocking drugs: A report from the Boston collaborative drug surveillance program
10. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
11. A long-term prevention study with oxprenolol in coronary heart disease
12. One year's treatment with propranolol after myocardial infarction: Preliminary report of Norwegian multicentre trial
13. A randomized trial of propranolol in patients with acute myocardial infarction, I: Mortality results
14. Controlled trial of sotalol for one year after myocardial infarction
15. Long-term treatment with metoprolol after myocardial infarction: Effect on 3 year mortality and morbidity
16. MRC trial of treatment of mild hypertension: Principal results
17. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension: Report of Medical Research Council Working Party on Mild to Moderate Hypertension
18. Randomised trial of treatment of hypertension in elderly patients in primary care
19. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
20. Antihypertensive efficacy and side effects of three beta-blockers and a diuretic in elderly hypertensives: A report from the STOP-Hypertension study
21. Medical Research Council trial of treatment of hypertension in older adults: Principal results
22. Treatment of Mild Hypertension Study: Final results
23. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women
24. Comparison of a lifestyle modification program with propranolol use in the management of diastolic hypertension
25. The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension
26. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
27. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
28. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)
29. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure
30. Early or deferred zidovudine therapy in HIV-infected patients without an AIDS-defining illness
31. Practical aspects of using beta-adrenergic blockade in systolic heart failure
32. Direct evidence for an interaction of beta-adrenergic blockers with the 5-HT receptor
33. Increased prescribing of antidepressants subsequent to beta-blocker therapy
34. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications
35. Increased antidepressant use in patients prescribed β-blockers
36. Beta-blockers and depression: Evidence against an association
37. Beta-blockers an important cause of depression: A medical myth without evidence
38. Beta blockers and fatigue
39. Propranolol erectile dysfunction relieved
40. The impact of first-line antihypertensive drugs on erectile dysfunction
41. Beta-blockers and central nervous system side effects